322 related articles for article (PubMed ID: 19260807)
21. Take off your genes and let the doctor have a look: why the Mayo and Myriad decisions have invalidated method claims for genetic diagnostic testing.
Bergin C
Am Univ Law Rev; 2013; 63(1):173-217. PubMed ID: 25335200
[TBL] [Abstract][Full Text] [Related]
22. The paths around stem cell intellectual property.
Taymor KS; Scott CT; Greely HT
Nat Biotechnol; 2006 Apr; 24(4):411-3. PubMed ID: 16601720
[TBL] [Abstract][Full Text] [Related]
23. Patent on stem cell studies puts U.S. officials in bind.
Stolberg SG
N Y Times Web; 2001 Aug; ():A1, A16. PubMed ID: 12155477
[No Abstract] [Full Text] [Related]
24. Patentability of genetically engineered microorganisms.
Cooper A
JAMA; 1983 Mar; 249(12):1553-4. PubMed ID: 6338261
[TBL] [Abstract][Full Text] [Related]
25. Intellectual property. U.S. Patent Office casts doubt on Wisconsin stem cell patents.
Holden C
Science; 2007 Apr; 316(5822):182. PubMed ID: 17431141
[No Abstract] [Full Text] [Related]
26. Trends in the human embryonic stem cell patent field.
Karlsson U; Hyllner J; Runeberg K
Recent Pat Nanotechnol; 2007; 1(3):233-7. PubMed ID: 19076035
[TBL] [Abstract][Full Text] [Related]
27. Patents for genetically modified animals.
O'Connor KW
J Anim Sci; 1993; 71 Suppl 3():34-40. PubMed ID: 8505268
[TBL] [Abstract][Full Text] [Related]
28. A brief guide to understanding patentability and the meaning of patents.
Elliott GC
Acad Med; 2002 Dec; 77(12 Pt 2):1309-14. PubMed ID: 12480641
[TBL] [Abstract][Full Text] [Related]
29. Ethical questions to ponder in the European stem cell patent debate.
Curley D; Sharples A
J Biolaw Bus; 2006; 9(3):12-6. PubMed ID: 17152135
[TBL] [Abstract][Full Text] [Related]
30. DNA as patentable subject matter and a narrow framework for addressing the perceived problems caused by gene patents.
Schilling SH
Duke Law J; 2011 Dec; 61(3):731-73. PubMed ID: 22165443
[TBL] [Abstract][Full Text] [Related]
31. Biomedical patents. Wisconsin stem cell patents upheld.
Holden C
Science; 2008 Mar; 319(5870):1602-3. PubMed ID: 18356497
[No Abstract] [Full Text] [Related]
32. Patenting of stem cells.
Williams G
Regen Med; 2006 Sep; 1(5):697-703. PubMed ID: 17465737
[TBL] [Abstract][Full Text] [Related]
33. Keeper of the stem cells.
Lemonick MD
Time; 2001 Aug; 158(8):57. PubMed ID: 11534482
[No Abstract] [Full Text] [Related]
34. Patentability of Parthenogenic Stem Cells: International Stem Cell Corporation v. Comptroller General of Patents.
Mansnérus J
Eur J Health Law; 2015 Jun; 22(3):267-86. PubMed ID: 26399046
[TBL] [Abstract][Full Text] [Related]
35. U.S. concedes some cell lines are not ready.
Stolberg SG
N Y Times Web; 2001 Sep; ():A1, A20. PubMed ID: 12156306
[No Abstract] [Full Text] [Related]
36. Patentable subject matter: morally neutral and context free.
Greenbaum D
Recent Pat DNA Gene Seq; 2011 Aug; 5(2):72-80. PubMed ID: 21592085
[TBL] [Abstract][Full Text] [Related]
37. Patents. U.S. Supreme Court delves into what is and isn't patentable.
Marshall E
Science; 2009 Jun; 324(5933):1374. PubMed ID: 19520926
[No Abstract] [Full Text] [Related]
38. Life forms protectable as subjects of US patents--microbes to animals (perhaps).
Hodgins DS
Appl Biochem Biotechnol; 1987; 16():79-93. PubMed ID: 3504131
[TBL] [Abstract][Full Text] [Related]
39. Patents: patenting of stem cell related inventions in Europe.
Rutz B; Yeats S
Biotechnol J; 2006 Apr; 1(4):384-7. PubMed ID: 16892264
[No Abstract] [Full Text] [Related]
40. Pharmaceutical patent life-cycle management after KSR v. Teleflex.
Furrow ME
Food Drug Law J; 2008; 63(1):275-320. PubMed ID: 18561462
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
